{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:14:54Z","timestamp":1787022894463,"version":"build-2736575974"},"reference-count":27,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,12,1]]},"abstract":"<jats:p>OBJECTIVE. Neonatal herpes simplex virus infections cause significant neonatal mortality and morbidity, but the course and prognosis in preterm infants is not well documented. We performed a retrospective review of herpes simplex virus infections at out institution within the first 30 days after birth in infants who were born at &amp;lt;37 weeks to help better define the symptoms and signs of herpes simplex virus infections in preterm infants and to assist in prognosis.<\/jats:p>\n                  <jats:p>METHODS. Hospital databases were reviewed to identify culture- or polymerase chain reaction\u2013proven cases of herpes simplex virus-1 or herpes simplex virus-2 infections that occurred in preterm newborns between 1989 and 2003. Maternal and neonatal histories, clinical features, and laboratory results were reviewed systematically.<\/jats:p>\n                  <jats:p>RESULTS. Ten preterm singletons and a set of twins were infected with herpes simplex virus-2 during the first month after birth. No mother had herpes simplex virus lesions at delivery, but a history of genital herpes simplex or other sexually transmitted infections was prevalent among the mothers. Infants presented with either disseminated disease or encephalitis. All infants with disseminated disease (n = 9) died, whereas the 3 infants with encephalitis survived. All infants in the cohort developed respiratory distress, and consistent with the prominence of respiratory symptoms, viral cultures of the respiratory tract were consistently positive. Ten of 12 infants received acyclovir, but despite treatment within 48 hours of symptoms, infants with disseminated disease deteriorated rapidly and died. Two of 3 infants who received high-dosage (60 mg\/kg per day) acyclovir survived.<\/jats:p>\n                  <jats:p>CONCLUSIONS. Herpes simplex virus infections in preterm infants usually present during the first 2 weeks of life with respiratory distress and a high incidence of disseminated disease. Viral respiratory cultures have a high yield for documentation of infection. The morbidity of herpes simplex virus in this population may be attributable to a relatively immature immune system in this population. Additional studies are necessary to delineate the evolution of herpes simplex virus disease in preterm infants and the role of antiviral therapy in mitigating the sequelae of herpes simplex virus infections in this population.<\/jats:p>","DOI":"10.1542\/peds.2005-1228","type":"journal-article","created":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T12:33:20Z","timestamp":1164976400000},"page":"e1612-e1620","source":"Crossref","is-referenced-by-count":52,"title":["Herpes Simplex Virus Infections in Preterm Infants"],"prefix":"10.1542","volume":"118","author":[{"given":"Declan P.","family":"O'Riordan","sequence":"first","affiliation":[{"name":"Eudowood Neonatal Pulmonary Division, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Christopher","family":"Golden","sequence":"additional","affiliation":[{"name":"Eudowood Neonatal Pulmonary Division, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan W.","family":"Aucott","sequence":"additional","affiliation":[{"name":"Eudowood Neonatal Pulmonary Division, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2006,12,1]]},"reference":[{"key":"2021120823121708800_R1","doi-asserted-by":"crossref","unstructured":"Kimberlin DW. Neonatal herpes simplex infection. Clin Microbiol Rev.\u20082004;17:1\u201313","DOI":"10.1128\/CMR.17.1.1-13.2004"},{"key":"2021120823121708800_R2","doi-asserted-by":"crossref","unstructured":"Arvin AM, Whitley RJ, Gutierrez KM. Herpes simplex virus infections. In: Remington JS, Klein JO, Wilson CB, Baker CJ, eds. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia, PA: Elsevier Saunders; 2006:845\u2013865","DOI":"10.1016\/B0-72-160537-0\/50028-1"},{"key":"2021120823121708800_R3","doi-asserted-by":"crossref","unstructured":"Kimberlin DW, Lin CY, Jacobs RF, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics.\u20082001;108:223\u2013229","DOI":"10.1542\/peds.108.2.223"},{"key":"2021120823121708800_R4","unstructured":"Brown Z. Preventing herpes simplex virus transmission to the neonate. Herpes\u20082004;11(suppl 3):175A\u2013186A"},{"key":"2021120823121708800_R5","doi-asserted-by":"crossref","unstructured":"Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med.\u20081997;337:509\u2013515","DOI":"10.1056\/NEJM199708213370801"},{"key":"2021120823121708800_R6","doi-asserted-by":"crossref","unstructured":"Whitley R, Arvin A, Prober C, et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med.\u20081991;324:450\u2013454","DOI":"10.1056\/NEJM199102143240704"},{"key":"2021120823121708800_R7","doi-asserted-by":"crossref","unstructured":"Whitley RJ, Nahmias AJ, Visintine AM, Fleming CL, Alford CA. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics.\u20081980;66:489\u2013494","DOI":"10.1542\/peds.66.4.489"},{"key":"2021120823121708800_R8","doi-asserted-by":"crossref","unstructured":"Koskiniemi M, Happonen JM, Jarvenpaa AL, Pettay O, Vaheri A. Neonatal herpes simplex virus infection: a report of 43 patients. Pediatr Infect Dis J.\u20081989;8:30\u201335","DOI":"10.1097\/00006454-198901000-00009"},{"key":"2021120823121708800_R9","doi-asserted-by":"crossref","unstructured":"Kimberlin DW, Lin CY, Jacobs RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics.\u20082001;108:230\u2013238","DOI":"10.1542\/peds.108.2.230"},{"key":"2021120823121708800_R10","unstructured":"Kimberlin D. Herpes simplex virus, meningitis and encephalitis in neonates. Herpes.\u20082004;11(suppl 3):65A\u201376A"},{"key":"2021120823121708800_R11","doi-asserted-by":"crossref","unstructured":"Sullender WM, Miller JL, Yasukawa LL, et al. Humoral and cell-mediated immunity in neonates with herpes simplex virus infections. J Infect Dis.\u20081987;155:28\u201337","DOI":"10.1093\/infdis\/155.1.28"},{"key":"2021120823121708800_R12","doi-asserted-by":"crossref","unstructured":"Bryson YJ, Winter HS, Gard SE, Fischer TJ, Strehm ER. Deficiency of immune interferon production by leukocytes of normal newborns. Cell Immunol.\u20081980;55:191\u2013200","DOI":"10.1016\/0008-8749(80)90150-1"},{"key":"2021120823121708800_R13","doi-asserted-by":"crossref","unstructured":"Cederblad B, Riesenfeld T, Alm GV. Deficient herpes simplex virus-induced interferon-alpha production by blood leukocytes of preterm and term newborn infants. Pediatr Res.\u20081990;27:7\u201310","DOI":"10.1203\/00006450-199001000-00002"},{"key":"2021120823121708800_R14","doi-asserted-by":"crossref","unstructured":"Kohl S, Shaban SS, Starr SE, Wood PA, Nahmias AJ. Human neonatal and maternal monocyte-macrophage and lymphocyte-mediated antibody-dependent cytotoxicity to cells infected with herpes simplex. J Pediatr.\u20081978;93:206\u2013210","DOI":"10.1016\/S0022-3476(78)80497-1"},{"key":"2021120823121708800_R15","doi-asserted-by":"crossref","unstructured":"Mintz L, Drew WL, Hoo R, Findey TN. Age-dependent resistance of human alveolar macrophages to herpes simplex virus. Infect Immun.\u20081980;28:417\u2013420","DOI":"10.1128\/iai.28.2.417-420.1980"},{"key":"2021120823121708800_R16","doi-asserted-by":"crossref","unstructured":"Gasparoni A, Ciardelli L, Avanzini A, et al. Age-related changes in intracellular TH1\/TH2 cytokine production, immunoproliferative T lymphocyte response, and natural killer cell activity in newborns, children, and adults. Biol Neonate.\u20082003;84:297\u2013303","DOI":"10.1159\/000073638"},{"key":"2021120823121708800_R17","doi-asserted-by":"crossref","unstructured":"Yeung CY, Hubbs JR. Serum-gamma-G-globulin levels in normal premature, post-mature, and \u201csmall for dates\u201d newborn babies. Lancet.\u20081968;1:1167\u20131170","DOI":"10.1016\/S0140-6736(68)91865-5"},{"key":"2021120823121708800_R18","unstructured":"Yoder MC, Polin RA. Developmental immunity. In: Fanaroff AA, Martin RJ, eds. Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant. St Louis, MO: Mosby; 1997:685\u2013717"},{"key":"2021120823121708800_R19","doi-asserted-by":"crossref","unstructured":"Kohl S, West MS, Prober CG, Sullender WM, Loo LS, Arvin AM. Neonatal antibody dependent cellular cytotoxic antibody levels are associated with the clinical presentation of neonatal herpes simplex virus infection. J Infect Dis.\u20081989;160:770\u2013776","DOI":"10.1093\/infdis\/160.5.770"},{"key":"2021120823121708800_R20","unstructured":"Boivin G. Diagnosis of herpesvirus infections of the central nervous system. Herpes.\u20082004;11(suppl 2):48A\u201356A"},{"key":"2021120823121708800_R21","doi-asserted-by":"crossref","unstructured":"Kimberlin DW, Lakeman FD, Arvin AM, et al. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Disease Collaborative Antiviral Study Group. J Infect Dis.\u20081996;174:1162\u20131167","DOI":"10.1093\/infdis\/174.6.1162"},{"key":"2021120823121708800_R22","doi-asserted-by":"crossref","unstructured":"Malm G, Forsgren M. Neonatal herpes simplex virus infections: HSV DNA in cerebrospinal fluid and serum Arch Dis Child Fetal Neonatal Ed.\u20081999;81:F24\u2013F29","DOI":"10.1136\/fn.81.1.F24"},{"key":"2021120823121708800_R23","doi-asserted-by":"crossref","unstructured":"Kimberlin DW, Whitley RJ. Neonatal herpes: what have we learned?Semin Pediatr Infect Dis.\u20082005;16:7\u201316","DOI":"10.1053\/j.spid.2004.09.006"},{"key":"2021120823121708800_R24","doi-asserted-by":"crossref","unstructured":"Fife KH, Bernstein DI, Tu W, et al. Predictors of herpes simplex virus type 2 antibody positivity among persons with no history of genital herpes. Sex Transm Dis.\u20082004;31:676\u2013681","DOI":"10.1097\/01.olq.0000143112.48835.9b"},{"key":"2021120823121708800_R25","doi-asserted-by":"crossref","unstructured":"Kimberlin D, Powell D, Gruber W, et al. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I\/II trial. Pediatr Infect Dis J.\u20081996;15:247\u2013254","DOI":"10.1097\/00006454-199603000-00014"},{"key":"2021120823121708800_R26","doi-asserted-by":"crossref","unstructured":"Tiffany KF, Benjamin DK Jr, Palasanthiran P, O'Donnell K, Gutman LT. Improved neurodevelopmental outcomes following long-term high-dose oral acyclovir therapy in infants with central nervous system and disseminated herpes simplex disease. J Perinatol.\u20082005;25:156\u2013161","DOI":"10.1038\/sj.jp.7211247"},{"key":"2021120823121708800_R27","doi-asserted-by":"crossref","unstructured":"Fonseca-Aten M, Messina AF, Jafri HS, Sanchez PJ. Herpes simplex virus encephalitis during suppressive therapy in a premature infant. Pediatrics.\u20082005;115:804\u2013809","DOI":"10.1542\/peds.2004-0777"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/6\/e1612\/1117465\/zpe012060e1612.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/6\/e1612\/1117465\/zpe012060e1612.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T17:41:40Z","timestamp":1683654100000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/118\/6\/e1612\/69727\/Herpes-Simplex-Virus-Infections-in-Preterm-Infants"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,1]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2006,12,1]]},"published-print":{"date-parts":[[2006,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2005-1228","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,1]]}}}